Lucerastat
Product Specifications
CAS Number
141206-42-0
Target
Transferase
Related Pathways
Metabolism
Purity
0.98
Bioactivity
Lucerastat (NBDGJ) is an orally available inhibitor of Glucosylceramide Synthase (GCS) with therapeutic potential for Fabry disease. GCS is a key enzyme in sphingolipid synthesis and inhibition of its activity reduces the accumulation of harmful substrates.
Smiles
C(CCC)N1[C@H](CO)[C@H](O)[C@H](O)[C@@H](O)C1
Molecular Formula
C10H21NO4
Molecular Weight
219.28
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
